Hospital Universitario de Valladolid -ko ikertzaileekin lankidetzan egindako argitalpenak (20)

2023

  1. Intravitreal allogeneic mesenchymal stem cells: a non-randomized phase II clinical trial for acute non-arteritic optic neuropathy

    Stem Cell Research and Therapy, Vol. 14, Núm. 1

2022

  1. Hair cortisol level as a molecular biomarker in retinitis pigmentosa patients

    Experimental Eye Research, Vol. 219

2021

  1. Long-term visual pathway alterations after elemental mercury poisoning: report of a series of 29 cases

    Journal of Occupational Medicine and Toxicology, Vol. 16, Núm. 1

2020

  1. Chemical compounds causing severe acute toxicity in heavy liquids used for intraocular surgery

    Regulatory Toxicology and Pharmacology, Vol. 110

  2. Matrix metalloproteinases in age-related macular degeneration (Amd)

    International Journal of Molecular Sciences, Vol. 21, Núm. 16, pp. 1-32

2019

  1. Acute retinal toxicity associated with a mixture of perfluorooctane and perfluorohexyloctane: Failure of another indirect cytotoxicity analysis

    British Journal of Ophthalmology, Vol. 103, Núm. 1, pp. 49-54

  2. Chemical considerations regarding the H-value methodology and its relation with toxicity determination

    Investigative Ophthalmology and Visual Science

  3. Development and evaluation of a head-mounted display system based on stereoscopic images and depth algorithms for patients with visual impairment

    Displays, Vol. 56, pp. 49-56

2018

  1. Comparison between direct contact and extract exposure methods for PFO cytotoxicity evaluation

    Scientific Reports, Vol. 8, Núm. 1

2017

  1. Acute retinal damage after using a toxic perfluoro-octane for vitreo-retinal surgery

    Retina, Vol. 37, Núm. 6, pp. 1140-1151

  2. Predictive models of long-term anatomic outcome in age-related macular degeneration treated with as-needed Ranibizumab

    BMC Ophthalmology, Vol. 17, Núm. 1

2015

  1. Loss of Visual Acuity after Successful Surgery for Macula-On Rhegmatogenous Retinal Detachment in a Prospective Multicentre Study

    Journal of Ophthalmology, Vol. 2015

2014

  1. Funduscopic results after 4-year follow-up treatment with ranibizumab for age-related macular degeneration in a region of Spain

    BMC Ophthalmology, Vol. 14, Núm. 1

2013

  1. External validation of existing formulas to predict the risk of developing proliferative vitreoretinopathy: The retina 1 project; Report 5

    Retina, Vol. 33, Núm. 8, pp. 1519-1527

2012

  1. A propensity score matching application: Indications and results of adding scleral buckle to vitrectomy: The Retina 1 project: Report 3

    European Journal of Ophthalmology, Vol. 22, Núm. 2, pp. 244-253

  2. Variations in Functional and Anatomical Outcomes and in Proliferative Vitreoretinopathy Rate along a Prospective Collaborative Study on Primary Rhegmatogenous Retinal Detachments: The Retina 1 Project—Report 4

    ISRN Ophthalmology, Vol. 2012, pp. 1-7

2011

  1. Training and professional profile of retinologists in Spain: Retina 2 project, Report 4

    Clinical Ophthalmology, Vol. 5, Núm. 1, pp. 483-490

2010

  1. PRPH2 (Peripherin/RDS) mutations associated with different macular dystrophies in a Spanish population: A new mutation

    European Journal of Ophthalmology, Vol. 20, Núm. 4, pp. 724-732

2008

  1. Non-complicated retinal detachment management: Variations in 4 years. Retina 1 project; report 1

    British Journal of Ophthalmology, Vol. 92, Núm. 4, pp. 523-525

  2. Surgical outcomes for primary rhegmatogenous retinal detachments in phakic and pseudophakic patients: The Retina 1 Project - Report 2

    British Journal of Ophthalmology, Vol. 92, Núm. 3, pp. 378-382